News
-
-
-
COMMUNIQUÉ DE PRESSE
Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use
Amoéba presents 2025 vineyard trial results confirming AXPERA's efficacy against downy mildew. AXPERA's performance in real conditions and response to French regulatory framework highlighted. Market authorization process and commercial launch details shared -
COMMUNIQUÉ DE PRESSE
Amoéba présente le bilan 2025 de sa campagne d'essais viticoles : AXPERA confirme son efficacité contre le mildiou et sa capacité à réduire fortement l'usage du cuivre
Amoéba présente les résultats des essais viticoles 2025 pour AXPERA, confirmant son efficacité contre le mildiou. Cadre réglementaire durci en France, démarches d'homologation en cours pour commercialisation en 2026 -
-
-
COMMUNIQUÉ DE PRESSE
Amoéba: Publication of the half-year financial report as of June 30, 2025
Amoéba announces the availability of its half-year financial report for the period ending June 30, 2025, filed with the French Financial Markets Authority. The report can be accessed on the company's website -
-
-
